OncoTherapy Science, Inc.

TSE:4564.T

32 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q4
Operating Activities:
Net Income -302-301-277-310-400-205-300-336-277-432-910-695-534-379-426-438-318-463-519-611-645-1,040-352-895-647-705-779-799-568-803-702-733-764-665-789-794-540-341-246-579-168-776-886-963-1,051475-459-374573.388565.799321.328-843.5231,631.449172.474-459.853-769.761,880.601
Depreciation & Amortization 00000000000000000000000000000000000000000000000047.75840.17136.59132.45835.34930.27127.07426.32238.662
Deferred Income Tax 0000000000000000000000000000000000000000000000003.999-1.264-2.415.74.73-0.033-1.6674.728-2.966
Stock Based Compensation 00000000000000000000000000000000000000000000000073.04458.64981.46456.96743.99145.9249.54415.07113.239
Change In Working Capital 000000000000000000000000000000000000000000000000-669.937-67.88181.75878.269321.649-127.338119.851-136.521-182.92
Accounts Receivables 000000000000000000000000000000000000000000000000000000000
Change In Inventory 00000000000000000000000000000000000000000000000011.9798.042-15.8945.2184.15514.788-10.2275.81-3.034
Change In Accounts Payables 000000000000000000000000000000000000000000000000000000000
Other Working Capital 000000000000000000000000000000000000000000000000-681.916-75.92397.65273.051317.494-142.126130.078-142.331-179.886
Other Non Cash Items 3023012773104002053003362774329106955343794264383184635196116451,0403528956477057797995688037027337646657897945403412465791687768869631,051-475459374-110.062118.045102.951-136.276-357.907283.751126.47-53.191183.78
Operating Cash Flow 000000000000000000000000000000000000000000000000-85.809714.783624.092-812.1051,674.531405.078-136.914-918.0791,933.362
Investing Activities:
Investments In Property Plant And Equipment 000000000000000000000000000000000000000000000000-50.014-70.343-79.282-42.281-44.004-41.95-19.244-16.594-41.288
Acquisitions Net 000000000000000000000000000000000000000000000000000000000
Purchases Of Investments 000000000000000000000000000000000000000000000000000000000
Sales Maturities Of Investments 000000000000000000000000000000000000000000000000000000000
Other Investing Activites 000000000000000000000000000000000000000000000000-14.385-2,510.3371,974.722-7.344-2,013.894-1,012.7-13.503-10.287-12.559
Investing Cash Flow 000000000000000000000000000000000000000000000000-50.69-2,565.3431,913.039-42.329-2,048.985-1,041.95-19.245-16.476-40.608
Financing Activities:
Debt Repayment 000000000000000000000000000000000000000000000000000000000
Common Stock Issued 00000000000000000000000000000000000000000000000025.356128.23925.8470.9699.321002.217
Common Stock Repurchased 000000000000000000000000000000000000000000000000000000000
Dividends Paid 000000000000000000000000000000000000000000000000000000000
Other Financing Activities 000000000000000000000000000000000000000000000000000000000.001
Financing Cash Flow 00000000000000000000000000000000000000000000000025.356128.23925.8470.9699.32114.23802.218
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000000000000000000000000000000021.28-6.13612.989-23.762-3.5853.2910.3390.190
Net Change In Cash 00-282.794-31.195-204.997139.967-335.884-192.4420000000000000000000000000000000000000000-89.861-1,844.6962,558.36-852.35-377.071-624.258-141.583-934.3651,895.136
Cash At End Of Period 00598.649881.443912.6381,117.635977.6681,313.55200000000000000000000000000000000000000005,562.5465,652.4077,497.1034,938.7435,791.0936,168.1646,792.4226,934.0057,868.37